title: Structure-based functional design of drugs: from target to lead compound.
abstract: Proteomic and genomic discoveries have identified vast numbers of new drug targets for investigation. In the quest to discover drugs that modulate the function of these targets, identification of small-molecule drug leads is one of the earliest steps. Structure-based drug design has emerged as a valuable, inexpensive, and rapid computational resource that identifies lead compounds that are complementary to the structure of the target. Leads identified through this process are biologically evaluated and "hit compounds" with affinity and activity are further optimized. This chapter introduces the process of structure-based drug design, including preparation of the ligand database, preparation of the target structure, docking and scoring, and evaluation.
authors.affiliation: School of Pharmacy, University of Connecticut, Storrs, CT, USA. Amy.anderson@uconn.edu
authors.forename: Amy C
authors.initials: AC
authors.lastname: Anderson
mesh_terms: D003198:Computer Simulation; D030562:Databases, Protein; D015195:Drug Design; D008024:Ligands; D021281:Quantitative Structure-Activity Relationship; D012984:Software
chemical_list: D008024:Ligands
references.citation: Proteins. 2008 Nov 15;73(3):566-80
references.pmid: 18473360
references.citation: J Med Chem. 2002 Jun 6;45(12):2615-23
references.pmid: 12036371
references.citation: J Comput Aided Mol Des. 1997 Jul;11(4):333-44
references.pmid: 9334900
references.citation: J Comput Chem. 2009 Dec;30(16):2785-91
references.pmid: 19399780
references.citation: J Med Chem. 2003 Jun 5;46(12):2287-303
references.pmid: 12773034
references.citation: Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
references.pmid: 11259830
references.citation: J Mol Biol. 1997 Feb 21;266(2):424-40
references.pmid: 9047373
references.citation: J Chem Inf Model. 2005 Jan-Feb;45(1):177-82
references.pmid: 15667143
references.citation: J Med Chem. 2003 Feb 13;46(4):499-511
references.pmid: 12570372
references.citation: Drug Discov Today. 2009 Apr;14(7-8):394-400
references.pmid: 19185058
references.citation: J Med Chem. 1985 Jul;28(7):849-57
references.pmid: 3892003
references.citation: J Chem Inf Model. 2009 Dec;49(12):2813-9
references.pmid: 19950979
references.citation: Br J Pharmacol. 2008 Mar;153 Suppl 1:S7-26
references.pmid: 18037925
references.citation: J Comput Aided Mol Des. 1992 Feb;6(1):61-78
references.pmid: 1583540
references.citation: J Med Chem. 2006 Oct 5;49(20):5912-31
references.pmid: 17004707
references.citation: Chem Biol. 2003 Sep;10(9):787-97
references.pmid: 14522049
references.citation: J Comput Aided Mol Des. 2006 Oct-Nov;20(10-11):601-19
references.pmid: 17149653
references.citation: Proteins. 1998 Oct 1;33(1):74-87
references.pmid: 9741846
references.citation: J Mol Biol. 1997 Apr 4;267(3):727-48
references.pmid: 9126849
references.citation: Nucleic Acids Res. 2000 Jan 1;28(1):235-42
references.pmid: 10592235
references.citation: J Med Chem. 2004 Mar 25;47(7):1739-49
references.pmid: 15027865
references.citation: Curr Opin Struct Biol. 2008 Apr;18(2):178-84
references.pmid: 18302984
references.citation: J Mol Biol. 1996 Aug 23;261(3):470-89
references.pmid: 8780787
references.citation: Phys Chem Chem Phys. 2010 Oct 28;12(40):12899-908
references.pmid: 20730182
references.citation: Curr Opin Chem Biol. 2007 Oct;11(5):494-502
references.pmid: 17936059
references.citation: J Med Chem. 2005 Feb 24;48(4):962-76
references.pmid: 15715466
references.citation: Proteins. 1999 Jan 1;34(1):4-16
references.pmid: 10336382
references.citation: Curr Med Chem. 2006;13(11):1283-304
references.pmid: 16712470